高盛-甘李药业(603087.SS):业绩点评:2026年上半年营收符合预期,净利润因非经营性项目略不及预期,维持买入-Gan&Lee Pharmaceuticals Co.(603087.SS):Earnings review:1H26 revenue in line while NP slightly miss due to non-opera-20260826【6页】

发表回复

后才能评论